Cargando…
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to Immunotherapy
Aging is associated with an increased incidence of cancer. One contributing factor could be modulation of immune cells responsible for anti-tumor responses, such as dendritic cells (DCs) and T cells. These immunological changes may also impact the efficacy of cancer immunotherapies in the elderly. T...
Autores principales: | Gardner, Joanne K., Jackaman, Connie, Mamotte, Cyril D. S., Nelson, Delia J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287204/ https://www.ncbi.nlm.nih.gov/pubmed/30560130 http://dx.doi.org/10.3389/fmed.2018.00337 |
Ejemplares similares
-
Mesothelioma Tumor Cells Modulate Dendritic Cell Lipid Content, Phenotype and Function
por: Gardner, Joanne K., et al.
Publicado: (2015) -
Lipid-laden partially-activated plasmacytoid and CD4(−)CD8α(+) dendritic cells accumulate in tissues in elderly mice
por: Gardner, Joanne K, et al.
Publicado: (2014) -
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation
por: Gardner, Joanne K., et al.
Publicado: (2018) -
Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
por: Duong, Lelinh, et al.
Publicado: (2018) -
Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy
por: Jin, Honglin, et al.
Publicado: (2016)